If you have dealt with septic arthritis — or are recovering from it, trying to prevent a recurrence, or watching a family member navigate it — you already know the standard conversation: antibiotics, drainage, rest.

Living with fibromyalgia means carrying a condition that most people around you cannot see, measure on a standard blood test, or fully understand. The pain is real. The exhaustion is real. The cognitive fog that makes a normal conversation feel like running a marathon is real.

If you or someone close to you has been dealing with Lyme disease — or suspect a chronic, unresolved form of it — you already know the frustration of being told your tests are "normal" while feeling anything but.

Living with hemophilia is not one experience. It ranges from barely noticeable mild cases discovered incidentally before surgery to severe presentations where spontaneous bleeds into joints begin in childhood and compound into lifelong disability.

When a child is diagnosed with juvenile idiopathic arthritis, the information families receive is often framed almost entirely around medication decisions. What gets left out — what most clinical appointments rarely have time to address — is the monitoring layer: the specific markers that reveal what is happening beneath the surface, why the disease is behaving a certain way in this particular child, and which levers are available to pull before or alongside pharmacological treatment.

Paget's disease of bone is often discovered before it is ever felt. A routine metabolic panel shows an elevated alkaline phosphatase, a bone scan ordered for something else lights up in an unexpected place, and suddenly there is a diagnosis for a condition many physicians have not discussed with a patient in years.

You already know you are not sleeping well. You have probably tried the obvious fixes — earlier bedtimes, less caffeine, cooler rooms, phone-free nights. Some of it helped. Most of it helped less than it should have.

Most people who struggle with willpower are not weak-minded. They wake up with clear intentions, commit to goals that genuinely matter to them, and still find themselves overwhelmed, distracted, or giving in to impulses they told themselves they had under control.

You have probably tried more than one approach. Maybe you cut calories, added exercise, cleaned up your diet, and still found your results inconsistent or slower than expected. That gap between effort and outcome is real, and it deserves a better explanation than the usual advice.

You train consistently, you eat enough protein, you sleep reasonably well — and yet the results do not come at the rate you expect. Or they plateau in a way that no generic program seems to fix. This is one of the more frustrating positions an athlete or fitness-minded person can find themselves in: doing everything "right" by the textbook, yet not seeing the progress that peers or online comparisons suggest is possible.

If you are reading this, you are probably not looking for reassurance that blueberries are good for the brain. You want something more useful — a way to understand what is actually happening in your own body and why your current efforts may or may not be moving the needle.

If you or someone close to you is navigating osteosarcoma — whether newly diagnosed, in treatment, or in post-treatment surveillance — you already know how inadequate generic information can feel. Most online resources describe the disease in broad strokes: what it is, how it is staged, what standard treatment looks like.

Living with Ehlers-Danlos syndrome means navigating a body that behaves unpredictably. The joints that sublux without warning, the skin that bruises from a sleeve, the fatigue that sits far heavier than a night of poor sleep could explain — these are not imagined symptoms.

You have had your TSH checked. It came back "normal." But you still feel exhausted before noon, struggle to lose weight despite consistent effort, and experience a cognitive fog that no amount of sleep seems to fix.

Sarcoidosis is one of those conditions that tends to leave patients caught between two frustrating realities: the diagnosis comes after months or years of unexplained fatigue, breathlessness, or strange skin lesions, and then the management plan often amounts to "monitor it and treat symptoms if they get worse." For many people, that isn't enough.

If you have been dealing with quadriceps tendinitis for longer than a few weeks, you already know that the standard advice — rest, ice, stretch — does not tell the whole story. You may have rested. You may have stretched.

Haemochromatosis moves quietly. For years — sometimes decades — iron accumulates in the liver, pancreas, heart, and joints without producing symptoms specific enough to raise immediate concern. The fatigue gets attributed to stress, the joint stiffness to aging, the slightly abnormal bloodwork to a lab error.

A tibial fracture — whether from a high-impact accident, a stress fracture from repetitive loading, or a low-energy break associated with weakened bone — is rarely just bad luck. For most people, the fracture itself is the final event in a longer biological story: years of suboptimal bone remodeling, undetected nutritional gaps, or genetic variants that quietly tipped the balance between bone formation and bone loss.

If you or someone close to you has been diagnosed with pigmented villonodular synovitis — now increasingly classified under the broader term tenosynovial giant cell tumor (TGCT) — you already know that standard explanations rarely go far enough.

A chondrosarcoma diagnosis lands differently than most cancer diagnoses. It is a relatively rare malignancy — second most common primary bone cancer, but still uncommon enough that many patients struggle to find clinicians with deep experience.

Ewing's sarcoma is one of the rarest and most aggressive bone and soft tissue cancers, predominantly affecting children, adolescents, and young adults. If you or someone close to you has received this diagnosis, the volume of information to absorb is often overwhelming, and the pace of clinical appointments rarely leaves room for deeper questions.

If you or someone close to you has been diagnosed with a giant cell tumor of bone, you already know that the information available tends to fall into two extremes: overly clinical papers written for specialists, or vague reassurances that leave you with more questions than answers.

Rheumatic fever sits at an uncomfortable crossroads between infection and immunity. It begins with something as ordinary as a strep throat — a Group A Streptococcus pyogenes infection — yet in some people, the immune response spirals into something far more damaging: inflammation attacking the heart, joints, brain, and skin.

Living with Behçet's disease means navigating a condition that behaves differently in almost every person it affects. For one patient, the dominant burden is recurrent oral and genital ulcers. For another, it is ocular inflammation threatening vision.

Living with sickle cell disease — or supporting someone who does — means navigating a condition that carries a well-known name but a deeply personal reality. Two people with the same diagnosis can have dramatically different lives: one hospitalized several times a year, another reaching adulthood with relatively few crises.

When someone is managing a lymphoma diagnosis, monitoring remission, or investigating a family history of blood cancers, the instinct is to find clear signals — data that either confirms things are under control or flags a problem early.

Living with a leukemia diagnosis — whether your own or a loved one's — puts you in a position most people are completely unprepared for: suddenly, you are expected to make sense of a dense stream of lab results, genetic reports, and clinical recommendations.

Wilson's disease sits in a frustrating middle zone for many people who receive the diagnosis — or suspect they might have it. The condition is rare enough that most general practitioners see only a handful of cases in their careers, yet common enough that delayed diagnosis is well-documented in the medical literature.

If you have been living with Complex Regional Pain Syndrome, you already know how inadequate most explanations feel. The burning, the swelling, the hypersensitivity to touch or temperature — and the frustrating reality that many clinicians have little to offer beyond a combination of medications, physical therapy, and a cautious prognosis.

When a child suddenly refuses to put weight on one leg, or when an adult develops an unexplained deep ache in the hip that appeared without obvious cause, the experience is disorienting. Transient synovitis — an acute inflammation of the synovial membrane lining the hip joint — is the most common cause of acute hip pain in children between three and twelve years old, and it also affects adolescents and adults more often than most people realize.

Living with alkaptonuria means navigating a condition that most doctors encounter once in a career, if at all. The darkening urine, the joint pain that arrives decades before most people expect it, the slow accumulation of pigment in cartilage and connective tissue — these are not vague symptoms that fit a broad diagnostic category.

Mixed connective tissue disease occupies an uncomfortable diagnostic space. It borrows symptoms from lupus, systemic sclerosis, polymyositis, and rheumatoid arthritis — which means that for many people, the path to a confirmed diagnosis stretches across years, multiple specialists, and a frustrating string of "possible" or "overlap" diagnoses.

Sjögren's syndrome rarely arrives with a clear answer. Most people spend years — sometimes more than a decade — cycling through specialists, collecting partial diagnoses, and managing a constellation of symptoms that never quite fit a simple explanation.

Joint pain is one of the most common and least discussed complications of living with HIV. Studies consistently show that up to 60% of HIV-positive individuals will experience some form of musculoskeletal or joint involvement during the course of their illness — a figure that surprises many people, including some clinicians.

Living with relapsing polychondritis means navigating a condition that most physicians encounter only a handful of times in their careers. The average diagnostic delay runs between two and four years, and even after diagnosis, the treatment path often feels blunt — corticosteroids calibrated to quiet the most visible flares, with little attention paid to what is actually driving the inflammation beneath the surface.

Living with polymyositis means living with a condition that most people have never heard of — and that even many clinicians see rarely. The progressive proximal muscle weakness, the fatigue that goes far beyond tiredness, the uncertainty about flares: these experiences are real and specific, and they deserve more than a generic framework built around suppressing symptoms and waiting to see what happens next.

Calcium pyrophosphate deposition disease — often called CPPD or pseudogout — tends to get lumped in with other forms of arthritis, treated symptomatically, and left largely unexplained. If you have lived through a sudden, agonizing joint flare that looked like gout but tested negative for urate crystals, or if chondrocalcinosis showed up on imaging without anyone explaining what actually caused it, you likely know the frustration of being told to manage inflammation without anyone asking why the crystals formed in the first place.

If you have been told your thyroid is overactive, you already know what that feels like in your body — the racing heartbeat at rest, the heat you cannot shake, the weight that keeps dropping no matter how much you eat, the anxiety that seems to come from nowhere.

If you or someone close to you has been diagnosed with Marfan syndrome, you already know that the standard conversation often stops at a list of restrictions: avoid contact sports, monitor your aorta annually, see a cardiologist.

Living with lipoma arborescens means living with something most people — including many doctors — have never heard of. The swelling, the stiffness, the frustrating return of symptoms after arthroscopic treatment: these are real, and they deserve more than a shrug or a generic anti-inflammatory protocol.

Living with Fabry disease — or supporting someone who does — means navigating a condition that most physicians encounter only a handful of times in their careers. The rarity of this diagnosis often translates into delayed care, generic symptom management, and a frustrating gap between what patients experience and what standard protocols address.

Chikungunya infection tends to begin with a predictable script: sudden fever, intense joint pain, and the assumption that things will resolve in a few weeks. For many people, they do. But for a substantial portion — clinical studies suggest somewhere between 12% and 49% of those infected — joint pain persists for months or years after the virus has cleared.

Living with spondyloepiphyseal dysplasia means navigating a condition that touches nearly every physical dimension of life — from how the spine and joints developed in early childhood to how they hold up across decades of use.

Blastomycosis is not a condition most people have heard of until it upends their life. Caused by the environmental fungus Blastomyces dermatitidis, it begins as a lung infection — often mild enough to be dismissed as a stubborn pneumonia — and in a significant portion of cases disseminates to bone, skin, and joints.

Living with multiple myeloma — or trying to understand it from the outside — quickly reveals how thin most general health content actually is. Standard summaries describe it as a plasma cell cancer, list the main drug classes, and stop there.

A bone metastasis diagnosis leaves most people trapped between two conversations that never quite connect: the imaging appointment that shows what is there, and the symptom conversation about pain management.

If you are dealing with joint pain following a rubella infection or a rubella-containing vaccine — especially if you are a woman over twenty-five — you may have noticed that most medical guidance stops at "it should resolve on its own." For a significant subset of people, it does not.

Living with hypermobility syndrome means navigating a condition that most practitioners underestimate. Your joints bend further than they should, your pain doesn't follow a predictable pattern, and the advice you receive often amounts to "strengthen your core" and "work with a physio." That advice isn't wrong — but it is incomplete in ways that matter a great deal, particularly when symptoms remain persistent despite following standard protocols.

Hypoparathyroidism is not a condition most people have heard of until they are living it. The parathyroid glands, four tiny structures resting against the thyroid, quietly regulate calcium and phosphorus every minute of your life.

Spinal tuberculosis — also called Pott's disease — is one of the most serious forms of extrapulmonary TB. It can take months or even years to diagnose, and when it finally is, you are handed a long antibiotic regimen and often very little else.

Living with multiple sclerosis — or trying to prevent further progression after a recent diagnosis — means navigating an enormous amount of conflicting advice. Rest more. Exercise more. Eat this.

Living with muscular dystrophy — or caring for someone who does — means navigating a condition where the details matter enormously. The word "muscular dystrophy" covers dozens of genetically distinct diseases with different speeds of progression, different organ involvements, and different responses to the same interventions.

Living with spinal muscular atrophy — or caring for someone who does — means navigating a disease where the stakes are high, the science moves fast, and the gap between what specialists know and what gets communicated in a standard appointment can be significant.

Nail-patella syndrome is one of the few conditions where the genetic cause was nailed down decades ago — and yet, for most people living with it, that clarity has not translated into a genuinely useful roadmap.

If you or someone close to you has lived with the effects of poliomyelitis — or received a diagnosis of post-polio syndrome decades after the original infection — you already know that standard advice rarely fits.

Living with osteogenesis imperfecta — or watching a child navigate it — means living with a kind of uncertainty that most people never have to face. The bones break. Sometimes from something trivial. Sometimes from nothing at all.

Living with hereditary multiple exostoses means navigating a condition where the same diagnosis can produce wildly different lives. One person carries a handful of small, stable growths for decades. Another develops dozens of exostoses that compress nerves, limit joint mobility, and require repeated surgeries before they turn thirty.

A distal femur fracture is not simply a broken bone you wait to heal. It is a complex biological event shaped by your metabolic environment, your hormonal status, your nutritional state, and — in ways that are only now becoming clinically actionable — your genetic makeup.

A popliteal artery aneurysm is the most common peripheral artery aneurysm, yet it often goes undetected until a complication — thrombosis, embolism, or acute limb ischemia — demands urgent care. If you or someone close to you has received this diagnosis, or if you carry known risk factors such as a family history of aortic or peripheral aneurysm, you are probably wrestling with questions that routine appointments don't fully answer: Why did this happen?

Living with Turner syndrome means navigating a health landscape where standard guidance consistently falls short. This is a condition that touches nearly every organ system — heart, bones, thyroid, liver, metabolism — yet many women receive care that is fragmented by specialty, leaving them to assemble the bigger picture themselves.

Rhabdomyolysis - the rapid breakdown of skeletal muscle cells and the release of their contents into the bloodstream - is the kind of condition that does not announce itself with obvious warning signs until it is already serious.

Williams syndrome sits at a crossroads where remarkable human qualities — deep empathy, musical sensitivity, social warmth — meet serious medical vulnerabilities that are easy to miss until they become crises.

A tibial eminence fracture is a structurally precise injury. The bony intercondylar spine at the center of the tibial plateau — the site where the anterior cruciate ligament inserts into bone — fractures under hyperextension or torsional force.

Synovial sarcoma is one of the most molecularly defined cancers in existence. Despite its name suggesting a synovial origin, it arises from a different cellular lineage entirely and most commonly affects adolescents and young adults.

Being told you have an enchondroma — often discovered incidentally on an X-ray taken for something completely unrelated — puts you in a strange medical limbo. You are reassured it is almost certainly benign, advised to monitor it periodically, and then sent on your way.

If you have been diagnosed with osteoid osteoma, you have probably heard a version of the same script: it is benign, NSAIDs will manage the pain, and radiofrequency ablation is available when things become intolerable.

If you've had a meniscectomy — partial or total — and you're still dealing with pain, stiffness, or instability months or even years later, you're facing a situation that medicine handles poorly. Doctors often frame persistent symptoms as an expected consequence: meniscal tissue is gone, the joint adapts, and pain may follow.

A patellar sleeve fracture is not the kind of injury that announces itself with obvious warning signs. It happens when the cartilaginous sleeve surrounding the lower pole of the kneecap tears away — most often in a child or teenager during a jump, a sudden sprint, or a deceleration — and the X-ray may look deceptively subtle while the damage is anything but.

Being told you have a desmoid tumor in or around your knee is disorienting in a very specific way. These tumors are not classic cancers, they do not spread through the bloodstream, yet they can invade local tissue aggressively enough to threaten function and quality of life.

Living with hemophilia means managing a condition that most of the world, including most general practitioners, has never seen up close. Hemophilic pseudotumor — an encapsulated, progressively expanding mass of blood that forms when repeated bleeding goes unresolved — is one of the rarest and most serious complications that hemophilia can produce.

Septic bursitis of the knee is one of those conditions that looks deceptively simple on the surface. A swollen, red, painful bursa caused by a bacterial infection — the treatment seems obvious: drain it, give antibiotics, rest.

An arcuate ligament avulsion fracture sits at the intersection of trauma and biology. The injury itself — a small fragment of the fibular head pulled away by the arcuate ligament complex when the posterolateral corner of the knee fails — is well-defined mechanically.

A lymphangioma of the knee is one of the rarer diagnoses in musculoskeletal and vascular medicine — a benign but often stubborn malformation of the lymphatic vessels that causes persistent swelling, discomfort, and a great deal of uncertainty about what comes next.

If you've had an osteochondral allograft procedure and the recovery isn't going the way you expected, the advice you're likely hearing is still about rest, physical therapy, and time. That advice is reasonable, but it doesn't explain why some patients integrate their graft seamlessly while others experience progressive failure despite similar surgeries, similar rehabilitation, and similar effort.

If you developed joint pain, stiffness, or swelling while taking a medication and no clear cause turned up on imaging or basic bloodwork, you are not imagining it. Drug-induced arthritis is real, underrecognized, and affects a meaningful percentage of people on certain medications.

Paraneoplastic arthritis sits in one of the most diagnostically frustrating corners of rheumatology. Joint pain, swelling, and morning stiffness appear — sometimes weeks or months before a cancer is ever found — and the picture looks almost identical to rheumatoid arthritis or reactive arthritis.

If you've been told you have chondrocalcinosis — or calcium pyrophosphate deposition disease (CPPD) — the conversation with your doctor probably ended somewhere around "it looks like arthritis on your X-ray" and "we can manage the flares." That answer is not wrong.

Living with congenital ligamentous laxity means dealing with joints that move beyond their intended range — and the chronic pain, fatigue, and instability that often follow. Most people with this condition have heard the same advice for years: strengthen your muscles, do more physical therapy, work on stability.

Living with Maffucci syndrome means sitting at an unusual intersection of orthopedic, vascular, and oncological concerns — and too often, receiving guidance that amounts to "monitor and wait." The surveillance is legitimate, but the absence of anything actionable between appointments leaves many patients with a diagnosis and no map.

Ollier disease occupies an uncomfortable middle ground in medicine: it is rare enough to be poorly understood by most general practitioners, yet serious enough that the people living with it deal with bone deformity, chronic pain, leg length discrepancy, and a lifelong uncertainty about whether one of their enchondromas might be quietly turning malignant.

An aneurysmal bone cyst diagnosis carries a particular kind of confusion. The imaging looks alarming — cavernous, blood-filled spaces expanding inside bone, sometimes causing visible deformity or fracture risk — yet the pathologist calls it benign.

A simple bone cyst — also called a unicameral bone cyst — is a fluid-filled cavity that forms inside bone, most often in children and adolescents between the ages of five and fifteen. It typically shows up as an incidental finding on an X-ray, or after a fracture that happened with surprisingly little force.

Living with Klippel-Trenaunay syndrome (KTS) means navigating a condition that most doctors have seen only in textbooks. It is a rare congenital vascular disorder — affecting roughly 1 in 100,000 people — defined by a triad of port-wine birthmarks, abnormal vein development, and soft tissue or bone overgrowth, almost always asymmetric and confined to one limb.

Tibial hemimelia is one of the rarest congenital limb deficiencies known — roughly one in a million births — and yet the families who live with this diagnosis often describe a strange experience: a flood of surgical information paired with a near-complete silence about the underlying biology.

Living with fibular hemimelia — whether as the person born with this condition or as a parent navigating care decisions for a child — means dealing with a medical reality that doesn't fit standard health frameworks.

A liposarcoma diagnosis puts you in a strange position. The medical system mobilizes quickly around surgery, imaging, and sometimes systemic therapy — but the underlying molecular reality of your tumor, which genes are driving it and what biological signals it's producing, often stays buried in pathology reports that are hard to interpret and rarely translated into anything you can act on.

Fibrosarcoma of bone is one of the rarer primary malignant bone tumors, making up fewer than 5% of all bone sarcomas. Because it shares imaging characteristics with other bone lesions and carries no single defining molecular fingerprint visible on standard pathology, it often travels through a long diagnostic workup before a definitive answer arrives.

If you or someone you care for has been diagnosed with homocystinuria, or if elevated homocysteine keeps showing up in blood work without a clear explanation, you already know the frustration of getting advice that feels incomplete.

Receiving a diagnosis of telangiectatic osteosarcoma — or trying to understand this disease on behalf of someone you love — places you in an unusual position. This is one of the rarest subtypes of an already rare cancer.

Living with systemic mastocytosis often means years of unexplained symptoms before a diagnosis arrives, followed by the equally difficult task of understanding a disease that looks different in every patient.

Living with amplified musculoskeletal pain syndrome means experiencing a level of pain that is real, often severe, and yet largely invisible on standard tests. The bloodwork comes back normal. The MRI shows nothing.

Living with carcinoid syndrome often means navigating a long gap between what you feel and what gets measured. The flushing, the unpredictable diarrhea, the abdominal cramping that comes with no clear trigger — these symptoms are real and disruptive, but the standard oncology panel does not always capture what is actually driving them on any given day.

Multicentric Castleman Disease sits in a strange corner of medicine — serious enough to be life-altering, rare enough to be regularly missed, and complex enough that even experienced hematologists sometimes spend months before arriving at the right diagnosis.

Living with porphyria often means navigating a condition that most physicians encounter only a handful of times in their careers. The average time from first symptom to confirmed diagnosis is measured in years, not months.

A glomus tumor diagnosis tends to arrive with very little context. Whether the tumor is a small, painful nodule beneath a fingernail or a larger mass discovered in the neck, ear, or skull base — a condition clinicians may call a paraganglioma or glomus jugulare — most people leave their first appointment knowing very little beyond "we found something." The anatomy is unfamiliar, the genetic terminology is dense, and the standard clinical roadmap rarely addresses the questions that matter most to the person sitting in the chair: Why did this happen?

Living with atopic dermatitis means learning to read your own skin — noticing when it flares, guessing which trigger matters this time, and wondering why the same routine that worked last month suddenly fails.

If you have been dealing with urticaria for more than a few weeks — whether it is sudden welts after a meal, relentless nighttime flares, or hives that seem to appear without any obvious cause — you already know how frustrating it can be to get a useful answer.

Stevens-Johnson Syndrome is not a diagnosis anyone expects. One week you are taking a drug your doctor prescribed with confidence; the next week you are in a burn unit watching your skin detach in sheets.

If you have been through a shingles outbreak, you already know it is not the minor inconvenience it is sometimes described as. The burning rash, the hypersensitive skin, the exhaustion — and for roughly one in five people, the nerve pain that lingers for months or even years afterward as postherpetic neuralgia.

Septicemia — blood poisoning triggered when a pathogen enters the bloodstream and ignites a systemic inflammatory response — moves fast. Within hours, what begins as an infection can cascade into organ failure, coagulation collapse, and septic shock.

Living with erythropoietic protoporphyria means navigating a world designed around sunlight. A few minutes near a window, a walk to the car at noon, a afternoon drive with the sun angled through the glass — any of these can trigger burning pain that lasts for hours and leaves you exhausted long after the exposure ends.

Living with DADA2 — Deficiency of Adenosine Deaminase 2 — sits at an uncomfortable intersection: it is rare enough to be consistently misunderstood, yet severe enough to cause strokes in children, vascular damage across decades, and immune collapse that resembles several diseases at once.

Hyperimmunoglobulin E syndrome is one of those conditions that tends to frustrate people for years before a name is finally attached to it. The combination of recurrent skin infections, pneumonias that leave permanent holes in the lungs, eczema that never quite responds to standard treatment, and a laboratory value that seems almost impossibly high — IgE levels ten or even a hundred times above normal — does not fit neatly into any single specialty.

After an allogeneic stem cell or bone marrow transplant, the uncertainty is relentless. You watch for signs, follow every protocol your team prescribes, and still feel like the information you are receiving is reactive — that you are always catching up to what your body is doing rather than staying ahead of it.

Noonan syndrome is one of those conditions that can feel deeply isolating — not because it is rare in the grand scheme of genetic disorders, but because so much of the standard conversation around it stops at the diagnosis.

Most people who receive a pseudohypoparathyroidism diagnosis are handed a prescription for calcium supplements and calcitriol, scheduled for follow-up bloodwork every six months, and sent home. If you have lived with PHP for any length of time, you already know how incomplete that experience can feel.

Stiff-Person Syndrome sits in a strange place in medicine. It is rare enough that many neurologists encounter only a handful of cases in a career, yet for those living with it, the muscle rigidity, unpredictable spasms, and relentless anxiety can make ordinary life feel genuinely unmanageable.

If you were handed a Klinefelter syndrome (47,XXY) diagnosis and then a pamphlet that said "start testosterone therapy and follow up with your endocrinologist," you probably noticed the gap almost immediately.

Living with chronic, unexplained fatigue, persistent brain fog, or a strange tingling in your hands and feet can feel incredibly isolating. You might describe these sensations to others, only to be met with well-meaning but ultimately hollow advice about getting more sleep or managing your stress levels.